| Literature DB >> 34306069 |
Waleed Mohamed Fadlalla1, Ayman Hanafy1, Mahmoud Abdelhakim2, Hatem Aboulkassem1, El Sayed Ashraf1, Ahmed Abdelbary1.
Abstract
BACKGROUND: Laparoscopic radical cystectomy is a challenging surgical procedure; however, it has been largely abandoned in favor of the more intuitive robotic-assisted cystectomy. Due to the prohibitive cost of robotic surgery, the adoption of laparoscopic cystectomy is of relevance in low-resource institutes. Methodology. This is a randomized controlled trial comparing laparoscopic radical cystectomy (LRC) to open radical cystectomy (ORC) at a single institute. Each group included thirty patients. The trial was designed to compare both approaches regarding operative time, blood loss, transfusion requirements, length of hospital stay, time to oral intake, requirement of opioid analgesia, and complications.Entities:
Year: 2021 PMID: 34306069 PMCID: PMC8279872 DOI: 10.1155/2021/4731013
Source DB: PubMed Journal: Adv Urol ISSN: 1687-6369
Figure 1Flowchart of the study.
Figure 2Pfannenstiel incision is used to deliver the specimen and perform urinary diversion.
Baseline patient characteristics.
| Whole cohort | LRC | ORC |
| ||
|---|---|---|---|---|---|
| Age (years) | 59.02 ± 7.55 | 57.20 ± 8.38 | 60.83 ± 6.24 | 0.062 | |
| Follow-up (months) | 20.5 (16–24) | 20.4 (16–24) | 20.7 (17–24) | 0.6 | |
| Sex | Male | 47 (78.3%) | 22 (73.3%) | 25 (83.3%) | 0.532 |
| Female | 13 (21.7%) | 8 (26.7%) | 5 (16.7) | ||
| ASA | 1 | 22 (36.7%) | 12 (40%) | 10 (33.3%) | 0.838 |
| 2 | 35 (58.3%) | 17 (56.7%) | 18 (60%) | ||
| 3 | 3 (5%) | 1 (3.3%) | 2 (6.7%) | ||
| Body mass index (BMI) | 24.9 ± 2 (range: 20–28.5) | 24.9 ± 1.8 (range: 20.5–28) | 24.8 ± 2.1 (range: 20–28.5) | 0.8 | |
| Previous abdominal surgery | 8 (13.3%) | 4 (13.3%) | 4 (13.3%) | 1.00 | |
| Neoadjuvant chemotherapy | 22 (36.7%) | 14 (46.7%) | 8 (26.7%) | 0.18 | |
| SCr preoperative (mg/dl) | 1.12 ± 0.30 | 1.08 ± 0.25 | 1.15 ± 0.34 | 0.323 | |
| SCr 1st postoperative day (mg/dl) | 1.08 ± 0.19 | 1.03 ± 0.15 | 1.14 ± 0.20 | 0.026 | |
| Hb preoperative (gm/dl) | 12.00 ± 1.50 | 12.01 ± 1.46 | 11.98 ± 1.57 | 0.932 | |
| Hb 1st postoperative day (gm/dl) | 10.62 ± 1.25 | 10.70 ± 1.24 | 10.53 ± 1.29 | 0.611 | |
| Clinical T stage | cT1 | 10 (16.7%) | 5 (16.7%) | 5 (16.7%) | 0.920 |
| cT2 | 34 (56.7%) | 18 (60%) | 16 (53.3%) | ||
| cT3 | 16 (26.7%) | 7 (23.3%) | 9 (30%) | ||
| Clinical N stage | cN0 | 49 (81.7%) | 23 (76.7%) | 26 (86.7%) | 0.488 |
| cN1-3 | 11 (18.3%) | 7 (23.3%) | 4 (13.3%) | ||
| Diversion | Orthotopic | 9 (15%) | 4 (13.3%) | 5 (16.7%) | 0.99 |
| Ileal conduit | 51 (85%) | 26 (86.7%) | 25 (83.3%) | ||
LRC: laparoscopic radical cystectomy; ORC: open radical cystectomy; ASA: American Society of Anesthesiologists' classification; SCr: serum creatinine; Hb: hemoglobin. P value ≤0.05 is considered significant. Values are given in means ± SD or n (%).
Comparison of intraoperative estimated blood loss and required blood transfusion units between the LRC and ORC groups.
| LRC | ORC |
| ||
|---|---|---|---|---|
| Estimated blood loss (ml) | 437.33 ± 374.24 | 602.67 ± 432.44 | 0.119 | |
| RBCS transfusion (unit) | 0 | 23 (76.7%) | 16 (53.3%) | 0.207 |
| 1 | 3 (10%) | 3 (10%) | ||
| 2 | 2 (6.7%) | 8 (26.7%) | ||
| 3 | 1 (3.3%) | 2 (6.7%) | ||
| 4 | 1 (3.3%) | 1 (3.3%) | ||
Comparison of cystectomy and lymphadenectomy operative time (minutes) between the LRC and ORC groups.
| Whole cohort | LRC | ORC |
| |
|---|---|---|---|---|
| Total operative time (min) | 311.7 ± 110.5 | 394.8 ± 94.8 | 228.6 ± 39.2 | <0.001 |
| Cystectomy operative time (min) | 129.6 ± 76.2 | 194.7 ± 51.2 | 64.5 ± 20.9 | <0.001 |
| Lymphadenectomy operative time | 61.1 ± 15 | 66.5 ± 14 | 55.7 ± 14.2 | 0.002 |
Figure 3(a) Comparison of operative duration between open and laparoscopic cystectomy. (b) The difference in OR time between the first 15 laparoscopic cases (mean: 280 minutes ± 52) and the last 15 laparoscopic cases (mean: 242 minutes ± 49) (P=0.0488).
Comparison of postoperative outcomes and complications between LRC and ORC groups.
| Whole cohort ( | LRC ( | ORC ( |
| |
|---|---|---|---|---|
| Time to solids oral intake (days) | 7.35 ± 4.64 | 6.07 ± 3.62 | 8.63 ± 5.22 | 0.031 |
| LOS (days) | 11.82 ± 4.83 | 9.8 ± 4.13 | 13.83 ± 4.69 | 0.001 |
| Postoperative opioid requirement | 23 (38.3%) | 7 (23.3%) | 16 (53.3%) | 0.033 |
| Conversion from laparoscopy to open | 0 | 0 | N/A | |
| Seroma | 7 (11.7%) | 2 (6.7%) | 5 (16.7%) | 0.4 |
| Surgical site infection (SSI) | 3 (5%) | 1 (3.3%) | 2 (6.7%) | 0.99 |
| Urinary tract infection | 1 (1.7%) | 1 (3.3%) | 0 | 0.99 |
| Ileus | 10 (16.7%) | 2 (6.7%) | 8 (26.7%) | 0.02 |
| Urine leak | 4 (6.7%) | 2 (6.7%) | 2 (6.7%) | 0.99 |
| Small intestinal injury | 0 | 0 | 0 | 0.99 |
| Rectal injury | 1 (1.7%) | 0 | 1 (3.3%) | 0.99 |
| Anastomotic bowel leak | 4 (6.7%) | 2 (6.7%) | 2 (6.7%) | 0.47 |
| Abdominal wall dehiscence | 3 (5%) | 0 | 3 (10.3%) | 0.24 |
| Pneumonia | 2 (3.3%) | 0 | 2 (6.7%) | 0.47 |
| Pulmonary embolism | 2 (3.3%) | 1 (3.3%) | 1 (3.3%) | 0.99 |
| Hospital readmission | 7 (11.7%) | 2 (6.7%) | 5 (17.2%) | 0.4 |
| Mortality | 1 (1.7%) | 0 | 1 (3.3%) | 0.99 |
| Incisional hernia | 3 | 0 | 3/29 (10.3%) | 0.2 |
| Port-site recurrence | 0 | 0 | N/A |
DVT: deep vein thrombosis; LOS: length of stay; LRC: laparoscopic radical cystectomy; ORC: open radical cystectomy; N/A: not applicable; Total number of cases is 29 due to the presence of one postoperative mortality in the ORC group.
Pathologic outcome.
| Whole cohort | LRC | ORC |
| ||
|---|---|---|---|---|---|
| Pathological T stage | pT0 | 5 (8.3%) | 5 (16.7%) | 0 | 0.098 |
| pT1 | 3 (5%) | 1 (3.3%) | 2 (6.7%) | ||
| pT2a | 4 (6.7%) | 1 | 3 (10%) | ||
| pT2b | 6 (10%) | 2 (6.7%) | 4 (13.3%) | ||
| pT3a | 10 (16.7%) | 7 (23.3%) | 3 (10%) | ||
| pT3b | 25 (41.7%) | 11 (36.7%) | 14 (46.7%) | ||
| pT4a | 7 (11.7) | 3 (10%) | 4 (13.3%) | ||
| Positive margin | 1 (1.7%) | 0 | 1 (3.3%) | 0.99 | |
| LNs no. | 13.82 | 15.23 ± 4.14 | 11.97 ± 5.48 | 0.008 | |
| Recurrence | 12 (20.3%) | 5 (16.7%) | 7 (24.1%) | 0.7 | |
Total number of cases is 59 due to the presence of one postoperative mortality in the ORC group. Total number of cases is 29 due to the presence of one postoperative mortality in the ORC group.